CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial Function.

Saved in:
Bibliographic Details
Title: CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial Function.
Authors: Vyas HS; Chronobiology and Metabolic Endocrinology Lab, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, India., Jadeja RN; Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA 30912, USA., Vohra A; Chronobiology and Metabolic Endocrinology Lab, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, India., Upadhyay KK; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI 48104, USA., Thounaojam MC; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA., Bartoli M; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA., Devkar RV; Chronobiology and Metabolic Endocrinology Lab, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, India.
Source: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2023 Apr 25; Vol. 12 (5). Date of Electronic Publication: 2023 Apr 25.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101668981 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3921 (Print) Linking ISSN: 20763921 NLM ISO Abbreviation: Antioxidants (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2076-3921
DOI:10.3390/antiox12050997